脑膜炎球菌病在COVID-19后的时代:准备的时间
David E Bloom1, Paolo Bonanni2, Federico Martinón-Torres3,4,5
1Harvard T.H. Chan School of Public Health, Boston, MA, USA.
侵袭性脑膜炎球菌病 (IMD) 发病率在COVID-19期间下降,但由于疫苗接种缺口,现在正在增加. 优先考虑脑膜炎球菌疫苗接种计划对于公共卫生准备和实现全球脑膜炎消除目标至关重要.
科学领域:
- 流行病学 流行病学
- 公共卫生 公共卫生
- 疫苗学 疫苗学 疫苗学
背景情况:
- 随着COVID-19大流行,侵袭性脑膜炎球菌病 (IMD) 格局发生了重大变化,由于公共卫生措施,导致发病率下降.
- 疫情期间疫苗接种率下降造成了免疫缺口,可能增加了对IMD的易感性.
- 从IMD转向COVID-19疫苗接种的重点转变可能进一步影响了脑膜炎球菌免疫覆盖率.
研究的目的:
- 突出IMD的复苏以及重新优先考虑脑膜炎球菌疫苗接种计划的关键需要.
- 强调脑膜炎球菌疫苗除了直接预防疾病之外的更广泛的公共卫生益处.
- 倡导加强疫苗接种战略,以应对当前和未来的IMD风险.
主要方法:
- 在COVID-19大流行期间和之后全球IMD发病率趋势的分析.
- 审查疫苗接种覆盖率数据和公共卫生政策转变.
- 评估导致IMD风险增加的因素,包括免疫债务和病原体共发生率.
主要成果:
- 由于大流行的缓解措施,IMD发病率最初下降,但随后在几个国家增加,可能超过了大流行前的水平.
- 疫苗接种覆盖率差距扩大,使人口易感性增加.
- 诸如免疫债务和其他呼吸道病原体发病率增加等因素加剧了IMD风险.
结论:
- 尽管有流行病相关的干扰,脑膜炎球菌疫苗接种计划需要重新关注和优先考虑.
- 需要进行全面的卫生技术评估,才能充分利用脑膜炎球菌疫苗的好处.
- 快速采取行动以加强疫苗接种战略对于实现广泛覆盖和打击IMD发病率上升至关重要,与全球卫生目标保持一致.
更多相关视频
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
相关概念视频
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Steps in Outbreak Investigation
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment
